Ambu A/S (OTCMKTS:AMBBY) and Acadia Healthcare (NASDAQ:ACHC) Head-To-Head Survey

Ambu A/S (OTCMKTS:AMBBY) and Acadia Healthcare (NASDAQ:ACHC) are both mid-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, risk, valuation, dividends, profitability, analyst recommendations and institutional ownership.

Analyst Recommendations

This is a breakdown of current ratings and price targets for Ambu A/S and Acadia Healthcare, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ambu A/S	0	0	0	1	4.00
Acadia Healthcare	0	4	6	0	2.60

Acadia Healthcare has a consensus price target of $47.94, indicating a potential upside of 100.60%. Given Acadia Healthcare’s higher possible upside, analysts plainly believe Acadia Healthcare is more favorable than Ambu A/S.

Volatility & Risk

Ambu A/S has a beta of 0.9, meaning that its share price is 10% less volatile than the S&P 500. Comparatively, Acadia Healthcare has a beta of 0.93, meaning that its share price is 7% less volatile than the S&P 500.

Valuation & Earnings

This table compares Ambu A/S and Acadia Healthcare”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ambu A/S	$783.76 million	4.63	$34.17 million	$0.19	81.32
Acadia Healthcare	$3.15 billion	0.70	$255.61 million	$2.03	11.77

Acadia Healthcare has higher revenue and earnings than Ambu A/S. Acadia Healthcare is trading at a lower price-to-earnings ratio than Ambu A/S, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Ambu A/S and Acadia Healthcare’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Ambu A/S	6.21%	6.31%	4.97%
Acadia Healthcare	5.94%	8.72%	4.46%

Summary

Acadia Healthcare beats Ambu A/S on 7 of the 13 factors compared between the two stocks.

About Ambu A/S

Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products. It also provides cardiology products consisting of airway management and anaesthesia products, such as bronchoscopes, video laryngoscopes, double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers extrication collars, CPR breathing barriers, video laryngoscopes, and training manikins. The company was founded in 1937 and is headquartered in Ballerup, Denmark.

About Acadia Healthcare

Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities. Acadia Healthcare Company, Inc. was founded in 2005 and is headquartered in Franklin, Tennessee.